Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, is reporting the payment date for the distribution of shares of common stock, par value $0.0001 per share, of SRM Entertainment Inc. The announcement noted that the payment date remains subject to SRM’s amended registration statement on form S-1 along with the approval of the listing of the SRM common stock on NASDAQ and obtaining certain other approvals in connection with the offering. SRM is currently a majority-owned subsidiary of Jupiter Wellness, which is expected to spin-off tomorrow. “In the event that such registration statement is not declared effective or the SRM common stock is not approved for listing, the distribution will not be paid on such date and the spin-off transaction will not occur,” the company stated in the press release. “The company anticipates that the SRM common stock will begin trading on NASDAQ on Aug. 4, 2023.”
To view the full press release, visit https://ibn.fm/CNcL6
About Jupiter Wellness Inc.
Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products along with licensing royalties. For additional information about this company, visit www.JupiterWellnessInc.com.
NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork
